Wellington Management Company »

Ovid Therapeutics shares owned by Wellington Management Company

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Wellington Management Company from 13F filings

Historical chart of Wellington Management Company investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Wellington Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Wellington Management Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $278k 103k 2.69
2024-06-30 $89k 116k 0.77
2024-03-31 $680k 223k 3.05

More positions owned by Wellington Management Company

NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Eli Lilly & Co. (LLY)
Amazon (AMZN)
Merck & Co (MRK)
Mastercard Incorporated Cl A (MA)
Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Johnson & Johnson (JNJ)
Advanced Micro Devices (AMD)
Astrazeneca Ord (AZN)
Kla Corp Com New (KLAC)

View all positions for Wellington Management Company

Top funds holding Ovid Therapeutics

Jupiter Topco
Eventide Asset Management
BlackRock
Henderson Group
RA Capital Management
Affinity Asset Advisors
Vanguard Capital Management
ADAR1 Capital Management
Balyasny Asset Management
Adage Capital Partners GP
Federated Investors
Braidwell
Geode Capital Management
Silverarc Capital Management
Stempoint Capital

View all funds holding Ovid Therapeutics